Difference between revisions of "Nagata T, et al. Breast Cancer (2014) cited as Ref 87 in DOI: 10.1038/s41392-020-0110-5 (Q9350)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2014, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Page(s) (P105): 96-101, #quickstatements; #temporary_batch_1590074839150) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Property / Published In Name String | |||
| + | Breast Cancer | ||
| Property / Published In Name String: Breast Cancer / rank | |||
| + | Normal rank | ||
| Property / Volume | |||
| + | 21 | ||
| Property / Volume: 21 / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | Prognostic significance of NANOG and KLF4 for breast cancer (English) | ||
| Property / title: Prognostic significance of NANOG and KLF4 for breast cancer (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 96-101 | ||
| Property / Page(s): 96-101 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:30, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Nagata T, et al. Breast Cancer (2014) cited as Ref 87 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Nagata T
0 references
2014
0 references
Breast Cancer
0 references
21
0 references
Prognostic significance of NANOG and KLF4 for breast cancer (English)
0 references
96-101
0 references
